Accelerating Cf Research Lifearc Join us at our industry symposium and unlock the potential of collaborating with cystic fibrosis trust. find out how we can support your research and move your projects closer to those living with cystic fibrosis. Today cystic fibrosis trust and medical research charity lifearc announced they are co funding a £15m research programme to create a new translational innovation hub network that will fast track new research and treatments to improve lung health and quality of life for people with cf.
Home Lifearc The lifearc chronic respiratory infection translational challenge aims to accelerate innovation by developing new diagnostics and treatments to detect and manage infections for people living with cf much earlier. Aims of the cf amr syndicate the syndicate supports and accelerates the translation of new diagnostics and antimicrobials to the clinic by providing diligence work, scientific expertise, and funding. it connects academics, industry partners, clinicians and people living with cf (cystic fibrosis). Medical research charity lifearc and the cystic fibrosis trust are jointly investing £15 million in the translational innovation hub network for lung health and infection, which has been guided by the insights and experiences of people with cystic fibrosis (cf). “lifearc, cystic fibrosis trust and mdc have an aligned vision of lifting the limits of medicines r&d, accelerating the development of cf antimicrobials and diagnostics, and speeding up new treatments for people with cf.
Home Lifearc Medical research charity lifearc and the cystic fibrosis trust are jointly investing £15 million in the translational innovation hub network for lung health and infection, which has been guided by the insights and experiences of people with cystic fibrosis (cf). “lifearc, cystic fibrosis trust and mdc have an aligned vision of lifting the limits of medicines r&d, accelerating the development of cf antimicrobials and diagnostics, and speeding up new treatments for people with cf. About the event the lifearc translational science summit on mnd and rare dementias will showcase lifearc’s innovative work and expert… accelerating cf research: strategies for rapidly progressing your science to clinical impact join us at our industry symposium and unlock…. The lifearc chronic respiratory infection translational challenge (cri tc) is our ambitious programme to accelerate scientific innovation for people living with bronchiectasis (be) and cystic fibrosis (cf). Join us at our industry symposium supported by lifearc on wednesday 5 june at glasgow science centre and unlock the potential of collaborating with cystic fibrosis trust. Lifearc, as part of the cf amr syndicate, is providing £3m in collaborative funding to drug discovery innovators to accelerate the development of new treatments for people with cystic fibrosis.
Comments are closed.